CORTESI PAOLO ANGELO

Fornari, C., Antonacci, S., Stoppa, S., Mantovani, L., Castaman, G., Cortesi, P. (2026). Economic Implication of Targeting Higher Trough Level with Extended Half-Life FVIII Prophylaxis. FARMECONOMIA E PERCORSI TERAPEUTICI, 27(1), 13-20 [10.7175/fe.v27i1.1604]. Dettaglio

Negri, S., Fornari, C., Ye, L., Inzoli, A., Costa, C., Mantovani, L., et al. (2026). Cost-effectiveness analysis (CEA) of ovarian cancer preventive strategies for women with BRCA1/2 pathogenic variants: the role of surveillance. THE EUROPEAN JOURNAL OF HEALTH ECONOMICS [10.1007/s10198-026-01909-4]. Dettaglio

Gaudio, M., Floreani, A., Schivardi, G., Alaimo, D., Basilico, V., Lorenzetti, I., et al. (2026). From intravenous to subcutaneous pertuzumab/trastuzumab in breast cancer: Clinical and pharmacoeconomic drivers and barriers to switching. TUMORI, 112(1), 22-31 [10.1177/03008916251401048]. Dettaglio

Cortesi, P., Mezghani, M., Alshaikheid, M., Lunk, I., D'Orsi, M., Zurria, M., et al. (2026). Use of Aflibercept 8 mg for the Treatment of Diabetic Macular Edema in Italy: A Cost-Minimisation Analysis Based on an Indirect Treatment Comparison. ADVANCES IN THERAPY [10.1007/s12325-026-03553-z]. Dettaglio

Cortesi, P. (2026). Towards a value-based approach in hemophilia: indications from the FAR-BENE study. BLOOD TRANSFUSION, 24(1), 4-6 [10.2450/BloodTransfus.1260]. Dettaglio